These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2857524)

  • 1. Sulfasalazine-induced agranulocytosis.
    Jacobson IM; Kelsey PB; Blyden GT; Demirjian ZN; Isselbacher KJ
    Am J Gastroenterol; 1985 Feb; 80(2):118-21. PubMed ID: 2857524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Agranulocytosis in patients with ulcerative colitis treated with salazosulphapyridine].
    Søndergaard JO; Stage JG; Sprechler M
    Ugeskr Laeger; 1983 Jul; 145(29):2225-7. PubMed ID: 6137093
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis.
    Rubin R
    Am J Gastroenterol; 1994 May; 89(5):789-91. PubMed ID: 7909645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Granulocytopenia in treatment with salazopyrin].
    Kvarstein G; Hovdenak N
    Tidsskr Nor Laegeforen; 1988 Nov; 108(32):2982-3. PubMed ID: 2908084
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM; Greenberg GR
    Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Side effects of salicylazosulfapyridine therapy].
    Miller B
    Dtsch Med Wochenschr; 1980 Nov; 105(46):1596-7. PubMed ID: 6108200
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.
    Barber GB; Lee DE; Antonioli DA; Peppercorn MA
    Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestasis and fatal agranulocytosis complicating sulfasalazine therapy: case report and review of the literature.
    Mitrane MP; Singh A; Seibold JR
    J Rheumatol; 1986 Oct; 13(5):969-72. PubMed ID: 2880997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor.
    Fathallah N; Slim R; Rached S; Hachfi W; Letaief A; Ben Salem C
    Int J Clin Pharm; 2015 Aug; 37(4):563-5. PubMed ID: 25854308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azulfidine agranulocytosis with bone marrow, megakaryocytosis, histiocytosis and plasmacytosis.
    Jamshidi K; Arlander T; Garcia MC; Windschitl HW; Swaim WR
    Minn Med; 1972 Jun; 55(6):545-8. PubMed ID: 4402375
    [No Abstract]   [Full Text] [Related]  

  • 13. Chloroquine for mild to moderately active ulcerative colitis: comparison with sulfasalazine.
    Goenka MK; Kochhar R; Tandia B; Mehta SK
    Am J Gastroenterol; 1996 May; 91(5):917-21. PubMed ID: 8633581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Remission for a patient with ulcerative colitis after agranulocytosis by the side effect of salazosulfapyridine].
    Nakamura K; Takeshima F; Shiozawa K; Furusu H; Tomonaga M; Isomoto H; Ohmagari K; Mizuta Y; Murase K; Kohno S
    Nihon Naika Gakkai Zasshi; 2000 Jan; 89(1):139-41. PubMed ID: 10723929
    [No Abstract]   [Full Text] [Related]  

  • 15. [Salicylazosulfapyridine-induced agranulocytosis in a patient with ulcerative colitis, successfully treated with granulocyte colony-stimulating factor].
    Matsubayashi Y; Izumi Y; Mori Y; Itoh K; Morioka A; Tatsuta H; Hashimoto A; Kotera T; Itoh A; Jo I
    Nihon Shokakibyo Gakkai Zasshi; 1991 Jan; 88(1):87-90. PubMed ID: 1709218
    [No Abstract]   [Full Text] [Related]  

  • 16. Agranulocytosis associated with sulfasalazine.
    Dery CL; Schwinghammer TL
    Drug Intell Clin Pharm; 1988 Feb; 22(2):139-42. PubMed ID: 2894966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulphasalazine.
    Maddocks JL; Slater DN
    J R Soc Med; 1980 Aug; 73(8):587-8. PubMed ID: 6112274
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute ulcerative colitis--a rare complication of sulfasalazine therapy.
    Ruppin H; Domschke S
    Hepatogastroenterology; 1984 Aug; 31(4):192-3. PubMed ID: 6148297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of depression in the treatment of nonspecific ulcerative colitis with sulfasalazine].
    Rebrov VG; Lukomskiĭ MI
    Klin Med (Mosk); 1989 Aug; 67(8):106. PubMed ID: 2572723
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine.
    Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S; Matsumoto K; Kitagawa T; Yamamoto J
    Am J Gastroenterol; 1992 Nov; 87(11):1654-7. PubMed ID: 1359782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.